Viatris Announces $1.65B Deal To Acquire Pacira BioSciences For $36.50/Share In Cash; Expects Close By End Of 2026
Share
Why It Matters
Viatris is buying another medicine company called Pacira for 1.65 billion dollars. When a big company buys a smaller one, watch if it helps them make more money or if it costs too much.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.